Velo-cardio-facial syndrome (vcfs) is a congenital disorder with a markedly variable clinical expression. The majority of those affected have cognitive-behavioural symptoms and psychiatric problems. Most of the somatic characteristics can be treated effectively. The quality of life of patients with vcfs is therefore determined largely by cognitive and behavioural symptoms, including the increased risk of psychiatric disorders. On the basis of a case-study featuring a 41-year-old vcfs patient and by reviewing the literature we describe the psychiatric disorders that can occur in conjunction with this syndrome.status: publishe
Velo-cardio-facial syndrome (VCFS) is a genetic disorder associated with 22q11 deletion, a character...
In both Prader-Willi syndrome (PWS) and 22q11 deletion syndrome [velo-cardio-facial syndrome (VCFS)]...
OBJECTIVE: Velocardiofacial syndrome (VCFS) is associated with cognitive deficits and high rates of ...
The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at...
In this contribution the current status and recent findings of the behavioural phenotype in VCFS (22...
In this contribution the current status and recent findings of the behavioural phenotype in VCFS (22...
This is the first clinical description of a detailed psychological, speech, and language phenotype o...
This is the first clinical description of a detailed psychological, speech, and language phenotype o...
BACKGROUND: Individuals with velocardio-facial syndrome (VCFS), a genetic disorder associated with m...
Among the many features with which velocardiofacial syndrome (VCFS) may present, we review in this p...
Velocardiofacial syndrome (VCFS), the most frequent microdeletion syndrome identified in humans, is ...
Velocardiofacial syndrome (VCFS), also known as DiGeorge, conotruncal anomaly face, and Cayler syndr...
Velo-cardio-facial syndrome (VCFS) is characterized by a high prevalence of depression and anxiety d...
Velocardiofacial syndrome (VUS), the most frequent microdeletion syndrome identified in humans, is a...
Velocardiofacial syndrome (VCFS) is one of the most common genetic disorders that affect every major...
Velo-cardio-facial syndrome (VCFS) is a genetic disorder associated with 22q11 deletion, a character...
In both Prader-Willi syndrome (PWS) and 22q11 deletion syndrome [velo-cardio-facial syndrome (VCFS)]...
OBJECTIVE: Velocardiofacial syndrome (VCFS) is associated with cognitive deficits and high rates of ...
The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at...
In this contribution the current status and recent findings of the behavioural phenotype in VCFS (22...
In this contribution the current status and recent findings of the behavioural phenotype in VCFS (22...
This is the first clinical description of a detailed psychological, speech, and language phenotype o...
This is the first clinical description of a detailed psychological, speech, and language phenotype o...
BACKGROUND: Individuals with velocardio-facial syndrome (VCFS), a genetic disorder associated with m...
Among the many features with which velocardiofacial syndrome (VCFS) may present, we review in this p...
Velocardiofacial syndrome (VCFS), the most frequent microdeletion syndrome identified in humans, is ...
Velocardiofacial syndrome (VCFS), also known as DiGeorge, conotruncal anomaly face, and Cayler syndr...
Velo-cardio-facial syndrome (VCFS) is characterized by a high prevalence of depression and anxiety d...
Velocardiofacial syndrome (VUS), the most frequent microdeletion syndrome identified in humans, is a...
Velocardiofacial syndrome (VCFS) is one of the most common genetic disorders that affect every major...
Velo-cardio-facial syndrome (VCFS) is a genetic disorder associated with 22q11 deletion, a character...
In both Prader-Willi syndrome (PWS) and 22q11 deletion syndrome [velo-cardio-facial syndrome (VCFS)]...
OBJECTIVE: Velocardiofacial syndrome (VCFS) is associated with cognitive deficits and high rates of ...